Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02029443
Brief Title: ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (Btk) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia

First Submitted : January 6, 2014
First Submitted that Met QC Criteria : January 6, 2014
First Posted : January 8, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 30, 2019
Last Update Posted : February 1, 2019